Dose escalation pre-clinical trial of novel DOK7-AAV in mouse model of DOK7 congenital myasthenia
Congenital myasthenic syndromes are a group of inherited disorders characterized by defective neuromuscular transmission and fatigable muscle weakness. Causative mutations have been identified in over 30 genes, including DOK7, a gene encoding a post-synaptic protein crucial in the formation and stab...
Main Authors: | Cossins, J, Kozma, I, Canzonetta, C, Hawkins, A, Beeson, D, Sepulveda, P, Dong, YY |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2025
|
Similar Items
-
Mutations causing DOK7 congenital myasthenia ablate functional motifs in Dok-7.
by: Hamuro, J, et al.
Published: (2008) -
Congenital myasthenia: contrasting rapsyn and Dok-7 phenotypes
by: Palace, J
Published: (2010) -
EPHEDRINE TREATMENT RESULTS IN PROFOUND FUNCTIONAL IMPROVEMENTS IN DOK-7 CONGENITAL MYASTHENIA
by: Lashley, D, et al.
Published: (2009) -
Long-term muscle-specific overexpression of DOK7 in mice using AAV9-tMCK-DOK7
by: Yu-Ting Huang, et al.
Published: (2023-09-01) -
DOK7 congenital myasthenic syndrome.
by: Palace, J
Published: (2012)